Literature DB >> 3919478

Diversity in H-2 genes encoding antigen-presenting molecules is generated by interactions between members of the major histocompatibility complex gene family.

L R Pease.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3919478     DOI: 10.1097/00007890-198503000-00001

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  6 in total

1.  Gene conversion in the evolution of both the H-2 and Qa class I genes of the murine major histocompatibility complex.

Authors:  M Kuhner; S Watts; W Klitz; G Thomson; R S Goodenow
Journal:  Genetics       Date:  1990-12       Impact factor: 4.562

2.  Mitotic recombination in germ cells generated two major histocompatibility complex mutant genes shown to be identical by RNA sequence analysis: Kbm9 and Kbm6.

Authors:  J Geliebter; R A Zeff; R W Melvold; S G Nathenson
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

3.  Nature of polymorphism in HLA-A, -B, and -C molecules.

Authors:  P Parham; C E Lomen; D A Lawlor; J P Ways; N Holmes; H L Coppin; R D Salter; A M Wan; P D Ennis
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

4.  Molecular diversity at the self-incompatibility locus is a salient feature in natural populations of wild tomato (Lycopersicon peruvianum).

Authors:  B A Rivers; R Bernatzky; S J Robinson; W Jahnen-Dechent
Journal:  Mol Gen Genet       Date:  1993-04

5.  Organization and structure of the Qa genes of the major histocompatibility complex of the C3H mouse: implications for Qa function and class I evolution.

Authors:  S Watts; A C Davis; B Gaut; C Wheeler; L Hill; R S Goodenow
Journal:  EMBO J       Date:  1989-06       Impact factor: 11.598

6.  The tumor-rejection antigens of the 1591 ultraviolet fibrosarcoma. Potential origin and evolutionary implications.

Authors:  R Linsk; S Watts; A Fischer; R S Goodenow
Journal:  J Exp Med       Date:  1989-03-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.